Actinium Pharmaceuticals (ATNM) Leases (2021 - 2025)
Actinium Pharmaceuticals (ATNM) has disclosed Leases for 5 consecutive years, with $10000.0 as the latest value for Q4 2025.
- Quarterly Leases changed N/A to $10000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $10000.0 for FY2025, N/A changed from the prior year.
- Leases for Q4 2025 was $10000.0 at Actinium Pharmaceuticals, down from $1.2 million in the prior quarter.
- The five-year high for Leases was $2.6 million in Q2 2023, with the low at $1000.0 in Q3 2023.
- Average Leases over 5 years is $1.1 million, with a median of $496000.0 recorded in 2021.
- The sharpest move saw Leases tumbled 99.96% in 2023, then skyrocketed 183700.0% in 2024.
- Over 5 years, Leases stood at $58000.0 in 2021, then plummeted by 94.83% to $3000.0 in 2022, then skyrocketed by 76200.0% to $2.3 million in 2023, then fell by 19.7% to $1.8 million in 2024, then crashed by 99.46% to $10000.0 in 2025.
- According to Business Quant data, Leases over the past three periods came in at $10000.0, $1.2 million, and $15000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.